| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8446105 | European Journal of Cancer | 2012 | 10 Pages |
Abstract
Preoperative CRT does not prolong OS or PFS. pCR or LC do not qualify as surrogate for PFS or OS while PFS is surrogate. Phase III trials should use OS or PFS as primary endpoint.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
F. Bonnetain, J.F. Bosset, J.P. Gerard, G. Calais, T. Conroy, L. Mineur, O. Bouché, P. Maingon, O. Chapet, L. Radosevic-Jelic, N. Methy, L. Collette,